Your browser doesn't support javascript.
loading
Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial.
Liu, Xiaoqiu; Thompson, Jennifer; Dong, Haiyan; Sweeney, Sedona; Li, Xue; Yuan, Yanli; Wang, Xiaomeng; He, Wangrui; Thomas, Bruce; Xu, Caihong; Hu, Dongmei; Vassall, Anna; Huan, Shitong; Zhang, Hui; Jiang, Shiwen; Fielding, Katherine; Zhao, Yanlin.
Afiliación
  • Liu X; National Center for TB Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Thompson J; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Dong H; PATH China Office, Shanghai, China.
  • Sweeney S; Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK.
  • Li X; National Center for TB Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Yuan Y; Jilin Provincial Center for Disease Control and Prevention, Changchun, China.
  • Wang X; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
  • He W; Jiangxi Provincial Center for Disease Control and Prevention, Nanchang, China.
  • Thomas B; Arcady Group, Richmond, VA, USA.
  • Xu C; National Center for TB Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Hu D; National Center for TB Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Vassall A; Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK.
  • Huan S; Bill & Melinda Gates Foundation China Office, Beijing, China.
  • Zhang H; National Center for TB Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Jiang S; National Center for TB Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Fielding K; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Zhao Y; National Center for TB Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. Electronic address: zhaoyl@chinacdc.cn.
Lancet Glob Health ; 11(5): e693-e703, 2023 05.
Article en En | MEDLINE | ID: mdl-37061308
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis / Tuberculosis Pulmonar / Tuberculosis Resistente a Múltiples Medicamentos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Lancet Glob Health Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis / Tuberculosis Pulmonar / Tuberculosis Resistente a Múltiples Medicamentos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Lancet Glob Health Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido